Millennium Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $80.8K | Sell |
|
|||||
|
2024
Q2 | $782K | Sell |
|
|||||
|
2024
Q1 | $928K | Buy |
|
|||||
|
2023
Q4 | $1.1M | Buy |
|
|||||
|
2023
Q3 | $500K | Buy |
|
|||||
|
2023
Q2 | $567K | Buy |
|
|||||
|
2023
Q1 | $1.17M | Buy |
|
|||||
|
2022
Q4 | $1.16M | Buy |
|
|||||
|
2022
Q3 | $522K | Sell |
|
|||||
|
2022
Q2 | $1.44M | Buy |
|
|||||
|
2022
Q1 | $626K | Buy |
|
|||||
|
2021
Q4 | $927K | Buy |
|
|||||
|
2021
Q3 | $1.33M | Buy |
|
|||||
|
2021
Q2 | $732K | Sell |
|
|||||
|
2021
Q1 | $3.29M | Buy |
|
|||||
|
2020
Q4 | $1.55M | Buy |
|
|||||
|
2020
Q3 | $60 | Sell |
|
|||||
|
2020
Q2 | $178K | Sell |
|
|||||
|
2020
Q1 | $191K | Sell |
|
|||||
|
2019
Q4 | $269K | Sell |
|
|||||
|
2019
Q3 | $491K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $12K | Sell |
|
|||||
|
2018
Q3 | $323K | Buy |
|
|||||
|
2018
Q2 | $318K | Sell |
|
|||||
|
2018
Q1 | $2.17M | Buy |
|
|||||
|
2017
Q4 | $749K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $305K | Sell |
|
|||||
|
2016
Q4 | $472K | Buy |
|
|||||
|
2016
Q3 | $17K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $37K | Buy |
|
|||||
|
2014
Q3 | $29K | Buy |
|
|||||
|
2014
Q2 | $40K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $360K | Buy |
|